Prostate cancer clinical trials
Legacy Cancer Institute offers clinical trials for prostate cancer patients, including the one described here. Ask your doctor if you qualify for this one or others.
SWOG S1216: This is a Phase III trial comparing the effectiveness of two hormone treatments, Androgen Deprivation Therapy plus TAK-700 (Orteronel) with Androgen Deprivation Therapy plus Bicalutamide. This study is for patients newly diagnosed with hormone-sensitive prostate cancer which has spread and are either beginning hormone therapy for the first time or have been on hormone therapy for less than 30 days. TAK-700 provided by a pharmaceutical partner.
Legacy Cancer Institute offers additional trials for cancer patients.
Search all clinical trials.